• 1. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 2. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoindoles and derivatives Isoindolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoindoles and derivatives Isoindolines Isoindolones

1,3-Dioxoisoindoline-5-carboxylic acid (CAS No. 20262-55-9): An Overview of Its Structure, Properties, and Applications in Medicinal Chemistry

1,3-Dioxoisoindoline-5-carboxylic acid (CAS No. 20262-55-9) is a versatile compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of dioxoisoindolines, which are characterized by a six-membered ring with two oxygen atoms and a carboxylic acid group at the C-5 position. The structure of 1,3-dioxoisoindoline-5-carboxylic acid makes it an attractive scaffold for the development of novel therapeutic agents.

The chemical structure of 1,3-dioxoisoindoline-5-carboxylic acid can be represented as C₉H₆O₄. The presence of the dioxoisoindoline core and the carboxylic acid group imparts several important properties to this compound. The dioxoisoindoline ring is known for its rigidity and planarity, which can enhance the binding affinity of the molecule to specific biological targets. Additionally, the carboxylic acid group provides a functional handle for further chemical modifications, enabling the synthesis of a wide range of derivatives with diverse biological activities.

In recent years, significant research efforts have been directed towards understanding the biological properties of 1,3-dioxoisoindoline-5-carboxylic acid. One of the key areas of interest is its potential as an inhibitor of various enzymes involved in disease pathways. For instance, studies have shown that certain derivatives of 1,3-dioxoisoindoline-5-carboxylic acid exhibit potent inhibitory activity against histone deacetylases (HDACs), which are important epigenetic regulators implicated in cancer and other diseases. HDAC inhibitors have shown promise in clinical trials for their ability to induce cell cycle arrest, apoptosis, and differentiation in cancer cells.

Beyond HDAC inhibition, 1,3-dioxoisoindoline-5-carboxylic acid and its derivatives have also been explored for their anti-inflammatory properties. Inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (IBD) are characterized by chronic inflammation and tissue damage. Research has demonstrated that certain dioxoisoindoline-based compounds can effectively reduce inflammation by modulating key signaling pathways involved in the inflammatory response. For example, a study published in the Journal of Medicinal Chemistry reported that a derivative of 1,3-dioxoisoindoline-5-carboxylic acid exhibited significant anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6.

The synthetic accessibility of 1,3-dioxoisoindoline-5-carboxylic acid is another factor that contributes to its appeal in medicinal chemistry. Various synthetic routes have been developed to access this scaffold efficiently. One common approach involves the reaction of phthalic anhydride with an appropriate nucleophile followed by oxidation to introduce the carboxylic acid group. This synthetic flexibility allows chemists to explore a wide range of structural modifications to optimize the biological properties of the final compounds.

In addition to its potential therapeutic applications, 1,3-dioxoisoindoline-5-carboxylic acid has also been studied for its use as a building block in supramolecular chemistry. The rigid and planar nature of the dioxoisoindoline core makes it suitable for constructing well-defined supramolecular assemblies with specific functions. For example, researchers have utilized dioxoisoindolines as components in self-assembling systems designed for drug delivery or sensing applications.

The safety profile of 1,3-dioxoisoindoline-5-carboxylic acid is another important consideration for its potential use in medicinal applications. Preclinical studies have generally shown that this compound and its derivatives exhibit good safety margins when administered at therapeutic doses. However, as with any new chemical entity, thorough toxicity evaluations are essential before advancing these compounds into clinical trials.

In conclusion, 1,3-dioxoisoindoline-5-carboxylic acid (CAS No. 20262-55-9) represents a promising scaffold with diverse applications in medicinal chemistry. Its unique structural features and potential biological activities make it an attractive target for further research and development. As ongoing studies continue to uncover new insights into the properties and applications of this compound, it is likely that we will see more innovative uses of dioxoisoindolines in both therapeutic and supramolecular contexts.

• 23386-41-6(3-Oxoisoindoline-5-carboxylic acid)
• 137247-85-9(2-Ethyl-1,3-dioxoisoindoline-5-carboxylic acid)
• 771-07-3(7-(hydroxymethyl)-2,3-dihydro-1H-isoindol-1-one)
• 926307-97-3(2,3-Dihydro-5-(hydroxymethyl)-1H-isoindol-1-one)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)